OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Refine your search

     By Application 

     By Reactivity

     By Host 

     By Product Line 

spacer

Multi-Clone Order
Not sure which antibody to choose? Want to screen multiple clones to find the optimal antibody for your research?

OriGene provides discount on the purchase of 3 or more TrueMAB antibodies against the same protein. Email your request to antibody@origene.com

OriGene also offers service of developing antibody pairs for immunoassays. Contact us at Assays@origene.com

4 matches found for "CD33"

divider

  Page: 1 of 1 

     CD33 Antibodies(4)

Spacer
Anti-CD33 Antibody [Clone OTI2F8]
Recommended for:
Description: Luminex and ELISA validated biotinylated CD33 mouse monoclonal antibody (clone 2F8), clone OTI2F8 (formerly 2F8)
Applications: ELISA, Luminex
Reactivity: Human
2 Images
spacer
Spacer
Anti-CD33 Antibody [Clone OTI1E10]
Description: Luminex and ELISA validated biotinylated CD33 mouse monoclonal antibody (clone 1E10), clone OTI1E10 (formerly 1E10)
Applications: ELISA, Luminex
Reactivity: Human
3 Images
spacer
Spacer
Anti-CD33 Antibody [Clone OTI1C4]
Description: Luminex and ELISA validated biotinylated CD33 mouse monoclonal antibody (clone 1C4), clone OTI1C4 (formerly 1C4)
Applications: ELISA, Luminex
Reactivity: Human
2 Images
spacer
Spacer
Anti-CD33 Antibody [Clone OTI1B10]
Description: Luminex and ELISA validated biotinylated CD33 mouse monoclonal antibody (clone 1B10), clone OTI1B10 (formerly 1B10)
Applications: ELISA, Luminex
Reactivity: Human
4 Images
spacer

 

pattern
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title